相似文献
1
Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
Catheter Cardiovasc Interv. 2010 Feb 1;75(2):301; author reply 302. doi: 10.1002/ccd.22253.
2
Patent foramen ovale closure and subsequent atrial fibrillation.
Catheter Cardiovasc Interv. 2009 Nov 15;74(6):896. doi: 10.1002/ccd.22305.
3
New onset atrial fibrillation after patent foramen ovale closure.
Catheter Cardiovasc Interv. 2009 Nov 15;74(6):889-95. doi: 10.1002/ccd.22172.
4
Nickel allergy and device closure of the patent foramen ovale, now that we were told should we care?
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):652. doi: 10.1002/ccd.22242.
5
Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1070-1. doi: 10.1002/ccd.22339.
6
Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):607-14. doi: 10.1002/ccd.22033.
7
Taming the "cobra": an approach to "cobra-like" formation seen in the Occlutech atrial septal defect and patent foramen ovale occluders.
Catheter Cardiovasc Interv. 2012 Mar 1;79(4):678-80. doi: 10.1002/ccd.23303. Epub 2011 Dec 12.
8
Device closure of patent foramen ovale--do similar devices achieve similar results?
Catheter Cardiovasc Interv. 2011 Apr 1;77(5):715. doi: 10.1002/ccd.23067.
9
Closing one hole leads to another: delayed aortic perforation following closure of a patent foramen ovale.
Catheter Cardiovasc Interv. 2010 Jul 1;76(1):135-6. doi: 10.1002/ccd.22677.
10
Patent foramen ovale--assessment and treatment.
Cardiovasc Ther. 2012 Jun;30(3):e128-35. doi: 10.1111/j.1755-5922.2010.00250.x. Epub 2011 Feb 15.
Zotero 插件